Paper5778426
Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy.
Charytan C and 1 other. N Engl J Med, 1969. Cited by 131 papers, by iCite.
Cite this record
ConductScience Library. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. Papers, record 5778426. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5778426
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Kidney Injury | Major topic |
| Aminocaproates | Major topic |
| Kidney Glomerulus | Major topic |
| Thrombosis | Major topic |
| Aged | |
| Biopsy | |
| Hematuria | |
| Humans | |
| Male | |
| Prostatic Neoplasms |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39954183 | Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: significance of guidelines developed for each underlying disease. | Int J Hematol | 2025 | https://conductscience.org/library/papers/39954183 | PubMed |
| 39792236 | Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalities. | Int J Hematol | 2025 | https://conductscience.org/library/papers/39792236 | PubMed |
| 39434960 | Distinguishing hyperfibrinolysis from enhanced-fibrinolytic-type disseminated intravascular coagulation. | Res Pract Thromb Haemost | 2024 | https://conductscience.org/library/papers/39434960 | PubMed |
| 38732176 | How We Interpret Thrombosis with Thrombocytopenia Syndrome? | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732176 | PubMed |
| 35163216 | Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163216 | PubMed |
| 33175341 | Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations. | Int J Hematol | 2021 | https://conductscience.org/library/papers/33175341 | PubMed |
| 32639181 | Consideration of Tranexamic Acid Administration to COVID-19 Patients. | Physiol Rev | 2020 | https://conductscience.org/library/papers/32639181 | PubMed |
| 31416465 | Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential. | Crit Care | 2019 | https://conductscience.org/library/papers/31416465 | PubMed |
| 28420841 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. | Intern Med | 2017 | https://conductscience.org/library/papers/28420841 | PubMed |
| 26071040 | Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. | BMC Pregnancy Childbirth | 2015 | https://conductscience.org/library/papers/26071040 | PubMed |
| 25520834 | Classifying types of disseminated intravascular coagulation: clinical and animal models. | J Intensive Care | 2014 | https://conductscience.org/library/papers/25520834 | PubMed |
| 20039075 | Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. | J Anesth | 2010 | https://conductscience.org/library/papers/20039075 | PubMed |
| 18386187 | Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage. | Neurocrit Care | 2008 | https://conductscience.org/library/papers/18386187 | PubMed |
| 14993107 | The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation. | Br J Pharmacol | 2004 | https://conductscience.org/library/papers/14993107 | PubMed |
| 9152974 | Acute promyelocytic leukaemia in the all trans retinoic acid era. | Med Oncol | 1996 | https://conductscience.org/library/papers/9152974 | PubMed |
| 8703716 | Protracted, gross hematuria in sickle cell trait: response to multiple doses of 1-desamino-8-D-arginine vasopressin. | Pediatr Nephrol | 1996 | https://conductscience.org/library/papers/8703716 | PubMed |
| 8647936 | Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8647936 | PubMed |
| 7580358 | Antifibrinolytic therapy in cardiac surgery. | Tex Heart Inst J | 1995 | https://conductscience.org/library/papers/7580358 | PubMed |
| 7435291 | Effect of antifibrinolytic therapy on subarachnoid fibrosis in dogs after experimental subarachnoid haemorrhage. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7435291 | PubMed |
| 7427206 | Acute renal failure and myopathy after treatment with aminocaproic acid. | Br Med J | 1980 | https://conductscience.org/library/papers/7427206 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5778426
GET https://conductscience.org/api/papers/v1/5778426/cited_by?page=2